Morbidity and Mortality of Hepatitis E Virus Infections in Belgium
Learn more about:
Related Access Program
Related Clinical Trial
Evaluation of Orthohepevirus C Infection as an Emerging Cause of Zoonotic Origin Disease
Morbidity and Mortality of Hepatitis E Virus Infections in Belgium
Study of the Immunogenicity and Efficacy of HBsAg Vaccine in Combination With Standard Antiviral Therapy With HB110E
Role of Cytokines in Hepatitis E Virus Infection During Pregnancy
Seroprevalence Hepatitis E Infection in Healthy Blood Donors
Safety Study of Hepatitis E Vaccine (HEV239)
Seroprevalence of Hepatitis E in People With an Organ Transplant
HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE)
Ribavirin for Severe Acute and Chronic Hepatitis E Virus Infection.
A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(Coadministration With Recombinant Hepatitis B Vaccine)
HEV in Patients With Acute Non-A, Non-B, Non-C Hepatitis in Al-Rajhy University Hospital for Liver
The Epidemiology of Hepatitis E Virus Infection in Israel and Potential Risk Factors
Phase Ⅳ Clinical Trial of Recombinant Hepatitis E Vaccine(Hecolin®)
A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)
Clinical Trial of Recombinant Hepatitis E Vaccine
A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Chronic Hepatitis B Patients )
A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Lot Consistency Trial)
Seroprevalence of Hepatitis E in HIV Positive Patients in Basque Country in 2016 (VIhVhEpb)
A Clinical Trial to Evaluate a Recombinant Hepatitis E Vaccine in Healthy Adults
A Study on the Recombinant Hepatitis E Vaccine (Escherichia Coli) (Accelerated Vaccination Schedule)